Aegros' chief executive, Damian Thornton, a 35‑year industry veteran brought in after a financial and board restructure, said the company’s 2025 capital raise was pivotal in addressing prior debt issues and unlocking completion of the facility without further government funding beyond R&D tax incentives. …
Aegros completes Australia’s second large scale plasma fractionation plant
July 8, 2026 Latest NewsAustralian BiotechBioPharma
Latest Video
New Stories
-
Vinnies named inaugural partner of Pharmacy Guild Foundation
August 18, 2026 - -
Opportunity #2 - AI can democratise HTA and the negotiations must not squander it
August 18, 2026 - - Latest News -
Opportunity #1 - biosimilar policy failure has become impossible to ignore
August 18, 2026 - -
Mesoblast completes treatment in pivotal low back pain trial as phase 3 readout approaches
August 17, 2026 - - Australian Biotech -
Dimerix takes control of US development pathway for new kidney injury treatment
August 17, 2026 - - Australian Biotech -
OncoSil secures FDA approval for targeted bile duct cancer device
August 17, 2026 - - Latest News -
Has any patient ever said they accept a rejection because of the Kaplan-Meier curve?
August 17, 2026 - - Latest News